Press release
Duchenne Muscular Dystrophy Market Size to Exceed USD 2.1 billion by 2031 | CAGR of 4.7%
Duchenne Muscular Dystrophy Market
Duchenne Muscular Dystrophy (DMD) is a genetic disorder that primarily affects males and is caused by mutations in the dystrophin gene. This gene encodes for a protein called dystrophin, which is crucial for maintaining the structural integrity of muscle fibers.
Individuals with DMD typically show signs of muscle weakness and wasting in early childhood, often beginning in the legs and pelvis and progressing to the upper body and arms. They may have difficulty walking, climbing stairs, or standing up from a seated position. As the disease progresses, individuals with DMD may develop scoliosis (curvature of the spine), respiratory and cardiac complications, and other health problems.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/16015
Top Duchenne Muscular Dystrophy Companies: -
• F Hoffmann-La Roche AG
• FibroGen, Inc
• GlaxoSmithKline plc
• Italfarmaco S.p.A.
• Nippon Shinyaku Co., Ltd
• Pfizer Inc.
• PTC Therapeutics
• Santhera Pharmaceuticals Inc
• Sarepta therapeutics
• Wave life sciences ltd.
Duchenne Muscular Dystrophy Market segmentation can be done based on several factors, including:
Based on therapeutic area, the molecular based therapies segment held the highest market share in 2021, accounting for around three-fifths of the global Duchenne muscular dystrophy market, and is estimated to maintain its leadership status throughout the forecast period. In addition, the same segment is projected to manifest the highest CAGR of 5.0% from 2022 to 2031, owing to R & D activities for exon skipping drugs, strong product pipeline and significant product launch by key players. The report also discusses steroid therapy segment.
Based on distribution channel, the hospital pharmacies segment accounted for the largest share in 2021, contributing to more than three-fifths of the global Duchenne muscular dystrophy market, and is projected to maintain its lead position during the forecast period. This is owing to significant rise in the number of diagnosis through hospitals. However, the drug store & retail pharmacies segment is expected to portray the largest CAGR of 5.4% from 2022 to 2031, owing to the rise in the approval of drugs and their availability in drug store & retail pharmacies.
Based on region, North America held the highest market share in terms of revenue in 2021, accounting for more than half of the global Duchenne muscular dystrophy market, and is likely to dominate the market during the forecast period. This is owing to technological advancements in Duchenne muscular dystrophy treatment and presence of key players & robust hospital infrastructure in the region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.9% from 2022 to 2031. This is owing to rise in cases of Duchenne muscular dystrophy, approval of drugs, development of healthcare infrastructure, and increase in investments projects in the region.
What are the Recent Trends in the Duchenne Muscular Dystrophy Market?
Rise in the incidence of the Duchenne muscular dystrophy (DMD) and surge in need for better healthcare services drive the growth of the global Duchenne muscular dystrophy market. However, inflated cost of treatments for Duchenne muscular dystrophy restricts the market growth. On the other hand, increase in government spending on the pharmaceutical and biotechnology sectors in developing countries, the development of healthcare infrastructure, and rise in demand for innovative treatments for Duchenne muscular dystrophy present new opportunities in the coming years.
Purchase the Report:
https://www.alliedmarketresearch.com/purchase-enquiry/16015
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?
By Region Outlook
• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Get Full Report:
https://www.alliedmarketresearch.com/duchenne-muscular-dystrophy-therapeutics-market
Top Trending Report:
AT-Home Testing Market: https://www.alliedmarketresearch.com/at-home-testing-market-A31866
Resuscitation Devices Market: https://www.alliedmarketresearch.com/resuscitation-devices-market-A11454
Gene Therapy Market: https://www.alliedmarketresearch.com/gene-therapy-market
3D Cell Culture Market: https://www.alliedmarketresearch.com/3d-cell-cultures-market
Molecular diagnostics market: https://www.alliedmarketresearch.com/molecular-diagnostics-market
Digital Pathology Market: https://www.alliedmarketresearch.com/digital-pathology-market
MRI Coils Market: https://www.alliedmarketresearch.com/mri-coils-market-A14839
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Duchenne Muscular Dystrophy Market Size to Exceed USD 2.1 billion by 2031 | CAGR of 4.7% here
News-ID: 2942364 • Views: …
More Releases from Allied Market Research (AMR)
Fiber Cement Market Analysis 2026-2030 Global Size, Segmentation Outlook, and Gr …
The rising need to reduce carbon emissions from the building and construction sector is significantly driving the growth of the global fiber cement market. As sustainability becomes a core focus across industries, fiber cement is emerging as a preferred material due to its durability, energy efficiency, and eco-friendly properties.
According to a report published by Allied Market Research titled "Fiber Cement Market by Raw Material (Portland Cement, Silica, Cellulosic Fibers, and…
Adhesives and Sealants Market Outlook 2026-2030 Industry Trends, Market Share, a …
The global adhesives and sealants market is witnessing steady growth, driven by rapid technological advancements, increasing R&D activities, and rising demand for electrical & electronic devices. In addition, growing government investments in building and construction projects across emerging and developed economies are significantly fueling market expansion.
According to a report published by Allied Market Research, the market was valued at $51.9 billion in 2020 and is projected to reach $85.0 billion…
Salicylic Acid Market Analysis 2026-2030 Global Size, Growth Trends and Competit …
The global salicylic acid market is witnessing steady growth, driven by rising demand from the preserved food & beverage industry and the expanding personal care sector. Increasing adoption in pharmaceuticals and cosmetics further strengthens market expansion.
According to Allied Market Research, the market was valued at $431.7 million in 2020 and is projected to reach $886.9 million by 2030, growing at a CAGR of 7.5% from 2020 to 2030.
Download Sample Pages…
Bottled Water Market Analysis 2026-2030 Latest Trends, Global Size, Share and Gr …
In a recently published report, Allied Market Research valued the global bottled water market at $301.7 billion in 2021. It also assessed the industry to reach $515.3 billion by 2031, rising a CAGR of 5.5% from 2022 to 2031.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/1802
What does the AMR research report include?
- The report examines competitive dynamics by analyzing business segments, product offerings, target market revenues, and geographical presence. It offers…
More Releases for Duchenne
Duchenne Muscular Dystrophy (DMD) Market Growth in 2034
Market Overview
The Duchenne Muscular Dystrophy (DMD) Market is expanding rapidly as advances in genetic medicine, exon-skipping therapies, gene therapy platforms, and improved diagnostic capabilities reshape treatment options for this severe, progressive neuromuscular disorder.
DMD is caused by mutations in the dystrophin gene, leading to muscle degeneration beginning in early childhood. Growing awareness among clinicians and caregivers, widespread adoption of next-generation sequencing (NGS), and increasing availability of disease-modifying therapies have significantly strengthened…
Duchenne Muscular Dystrophy: Core Growth Enabler in the Rising Prevalence Of Chr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Duchenne Muscular Dystrophy Industry Market Size Be by 2025?
The market size for Duchenne Muscular Dystrophy has shown significant expansion recently, burgeoning from $1.16 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The impressive growth in the…
Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market in 2025: Bit B …
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Expected to Be, and What Will Its Growth Rate Be?
The Duchenne muscular dystrophy (DMD) therapeutics market will grow from $11.95 billion in 2024 to $16.45 billion in 2025, at a CAGR of 37.6%. The growth is attributed to the increasing prevalence of Duchenne muscular dystrophy, rising awareness of treatment options, healthcare spending, and government initiatives.
The Duchenne muscular dystrophy (DMD) therapeutics…
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period
The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in…
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market…
